Outpatient Therapy in Metastatic Breast Cancer. A Retrospective Study of 90 Patients Treated in an Oncology Group Practice

Publisher： Karger

E-ISSN： 2296-5262|27|4|380-384

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.27, Iss.4, 2004-09, pp. : 380-384

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved Survival of Patients with Metastatic Breast Cancer in Routine Care: Results of a Retrospective Study in a Community-Based Oncology Group Practice 1995–2005

By  

Oncology Research and Treatment, Vol. 32, Iss. 3, 2009-02 ,pp. : 107-113

Karger

Access to resources Recommend Favorite

Weekly Docetaxel with or without Gemcitabine as Second-Line Chemotherapy in Paclitaxel-Pretreated Patients with Metastatic Breast Cancer: A Randomized Phase II Study Conducted by the Hellenic Co-Operative Oncology Group

By  

Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

Phase II Trial of Chemotherapy plus Bevacizumab as Second-Line Therapy for Patients with Metastatic Colorectal Cancer That Progressed on Bevacizumab with Chemotherapy: The Gunma Clinical Oncology Group (GCOG) trial 001 SILK Study

By  

Oncology, Vol. 83, Iss. 3, 2012-08 ,pp. : 151-157

Karger

Access to resources Recommend Favorite

Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group Trial

By  

Oncology, Vol. 85, Iss. 6, 2013-11 ,pp. : 328-335

Karger

Access to resources Recommend Favorite

Neurotoxicity as a Prognostic Factor in Patients with Metastatic Breast Cancer Treated with Ixabepilone as a First-Line Therapy

By  

Oncology, Vol. 88, Iss. 3, 2014-11 ,pp. : 180-188

Karger

Access to resources Recommend Favorite